| 000 | 01587 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514204608.0 | ||
| 264 | 0 | _c20050524 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a0929-1903 | ||
| 024 | 7 |
_a10.1038/sj.cgt.7700781 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalmels, Bastien | |
| 245 | 0 | 0 |
_aBypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L. _h[electronic resource] |
| 260 |
_bCancer gene therapy _cFeb 2005 |
||
| 300 |
_a198-205 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCD28 Antigens _xphysiology |
| 650 | 0 | 4 |
_aCD4 Antigens _xanalysis |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aCoculture Techniques |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMelanoma, Experimental _xgenetics |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xphysiology |
| 650 | 0 | 4 | _aTumor Necrosis Factors |
| 700 | 1 | _aPaul, Stéphane | |
| 700 | 1 | _aFutin, Nicolas | |
| 700 | 1 | _aLedoux, Catherine | |
| 700 | 1 | _aStoeckel, Fabienne | |
| 700 | 1 | _aAcres, Bruce | |
| 773 | 0 |
_tCancer gene therapy _gvol. 12 _gno. 2 _gp. 198-205 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.cgt.7700781 _zAvailable from publisher's website |
| 999 |
_c15164188 _d15164188 |
||